Taisho Pharmaceutical Holdings Co., Ltd.
OTC: TAIPY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Akira Uehara
- Employees
- 8,784
- Headquarters
- Tokyo, Japan
- IPO year
- 2021
- Market cap
- $18.1B
- Website
- https://www.taisho-holdings.co.jp
Loading TAIPY…
Loading profile data…Frequently asked questions about TAIPY
What does Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY) do?
Taisho Pharmaceutical Holdings Co., Ltd. is a global healthcare entity engaged in the comprehensive process of researching, developing, manufacturing, marketing, distributing, and selling both over-the-counter (OTC) and prescription pharmaceutical products. The company operates across Japan and internationally, structuring its diverse activities...
Where does TAIPY trade?
Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY) trades on the Other OTC.
What sector is TAIPY in?
Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Taisho Pharmaceutical Holdings Co., Ltd.?
Akira Uehara is the chief executive officer of Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY).
Where is Taisho Pharmaceutical Holdings Co., Ltd. headquartered?
Taisho Pharmaceutical Holdings Co., Ltd. is headquartered in Japan.
Does TAIPY pay a dividend?
Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TAIPY go public?
Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY) completed its initial public offering in 2021.
Is TAIPY an ADR?
Yes — TAIPY is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Taisho Pharmaceutical Holdings Co., Ltd. reporting and dividends follow the underlying issuer.